Synergic Control of Posture in Peripheral Neuropathies' Patients

计划入组 26 人 · 首次发布于 2021 年 10 月 22 日

Environmental Factors Associated With Peripheral Neuropathies in French Guiana

计划入组 78 人 · 首次发布于 2026 年 1 月 15 日

Quality of Life in Hereditary and Inflammatory Peripheral Neuropathies

计划入组 60 人 · 首次发布于 2026 年 1 月 14 日

SSTR4 agonist (peripheral pain)

peripherally-restricted NLRP3 inhibitor (peripheral neuropathy)

Programmed cellular immunotherapeutic (Fate Therapeutics)

Bard Peripheral Vascular, Inc.

United States

Cara Therapeutics

United States

Ventyx Biosciences

United States

Sangamo's ST-503 Receives FDA Clearance for iSFN Clinical Trials

Greenland Mines Secures Australian Patent for Klotho-Based Gene Therapy Targeting ALS and Neuromuscular Diseases

Nura Bio Secures $140 Million to Advance Neuroprotective Drug NB-4746 Targeting SARM1